@booklet {17602,
	title = {Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster},
	journal = {Free Radical Biology and MedicineFree Radical Biology and Medicine},
	volume = {65},
	year = {2013},
	pages = {1155-1163},
	publisher = {Elsevier},
	abstract = {Advanced glycation end product (AGE)-modified proteins are formed by the nonenzymatic glycation of free amino groups of proteins and, along with lipofuscin (a highly oxidized aggregate of covalently cross-linked proteins, sugars, and lipids), have been found to accumulate during aging and in several age-related diseases. As the in vivo effects of diet-derived AGEs or lipofuscin remain elusive, we sought to study the impact of oral administration of glucose-, fructose-, or ribose-modified albumin or of artificial lipofuscin in a genetically tractable model organism. We report herein that continuous feeding of young Drosophila flies with culture medium enriched in AGEs or in lipofuscin resulted in reduced locomotor performance and in accelerated rates of AGE-modified proteins and carbonylated proteins accumulation in the somatic tissues and hemolymph of flies, as well as in a significant reduction of flies health span and life span. These phenotypic effects were accompanied by reduced proteasome peptidase activities in both the hemolymph and the somatic tissues of flies and higher levels of oxidative stress; furthermore, oral administration of AGEs or lipofuscin in flies triggered an upregulation of the lysosomal cathepsin B, L activities. Finally, RNAi-mediated cathepsin D knockdown reduced flies longevity and significantly augmented the deleterious effects of AGEs and lipofuscin, indicating that lysosomal cathepsins reduce the toxicity of diet-derived AGEs or lipofuscin. Our in vivo studies demonstrate that chronic ingestion of AGEs or lipofuscin disrupts proteostasis and accelerates the functional decline that occurs with normal aging. {\textcopyright} 2013 Elsevier Inc.},
	keywords = {Advanced glycation end products, Aging, Cathepsin, Drosophila, free radicals, Lipofuscin, Lysosome, Proteasome},
	url = {http://dx.doi.org/10.1016/j.freeradbiomed.2013.08.186},
	author = {Tsakiri, Eleni N. and Iliaki, Kalliopi K. and H{\"o}hn, Annika and Grimm, Stefanie and Papassideri, Issidora S. and Grune, Tilman and Trougakos, Ioannis P.}
}
